Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Rexahn Pharmaceuticals (RNN)

1.85 -0.04 (-2.12%)

10/20/2017  4:00pm

Open:

1.89

Pre. Close:

1.89

High:

1.90

Low:

1.80

Volume:

447,015

Market Cap:

52.65M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.95 - 2.04

2.04 - 2.12

Low:

1.71 - 1.75

1.75 - 1.78

Close:

1.82 - 1.89

1.89 - 1.97

Technical analysis  (as of: 2017-10-20 4:39:51 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.11     One year: 3.73

Support:

Support1: 1.80    Support2: 1.50

Resistance:

Resistance1: 2.66    Resistance2: 3.19

Pivot:

2.41

Moving Averages:

MA(5): 1.95     MA(20): 2.41

MA(100): 2.49     MA(250): 1.42

MACD:

MACD(12,26): -0.10     Signal(12,26,9):

%K %D:

%K(14,3): 2.22     %D(3): 1.64

RSI:

RSI(14): 33.58

52-Week:

High: 4.74  Low: 0.13  Change(%): 988.2

Average Vol(K):

3-Month: 26126  10-Days 41783

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
RNN has closed above bottom band by 14.1%. Bollinger Bands are 95.5% wider than normal. The large width of the bands suggest high volatility as compared to RNN's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Tue, 05 Sep 2017 12:56:15 GMT
Rexahn Pharmaceuticals to Present at the 2017 Disruptive Growth Company ...

Fri, 06 Oct 2017 09:36:31 GMT
Seaport Global Securities Starts Rexahn Pharmaceuticals Inc. (RNN) at Buy

Tue, 10 Oct 2017 12:56:15 GMT
Rexahn Pharmaceuticals Receives Positive Opinion from European Medicines ...

Wed, 11 Oct 2017 11:37:30 GMT
Rexahn Pharmaceuticals (RNN) in Focus: Stock Moves 6.1% Higher October 11, 2017

Mon, 16 Oct 2017 16:07:30 GMT
Here's What We Want To See From Rexahn Pharmaceuticals Inc (NYSEMKT:RNN) Next

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

27.73

% Held by Insiders

2.58

% Held by Institutions

12.52

Shares Short (K)

1920

Shares Short Prior Month (K)

1790

Stock Financials

EPS

-1.010

EPS Est. Current Year

-1.280

EPS Est. Next Year

-0.680

EPS Est. Next Quarter

-0.250

Forward EPS

-0.710

Book Value (p.s.)

0.560

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-40.8

Return on Equity (ttm)

-151.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.557

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.88

Levered Free Cash Flow (M)

-8.66

FoxReading.com

Valuation

P/E

-1.83

P/E Growth Ratio

-0.02

P/BV

3.30

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-05-05

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.